Frequency of albuminuria in primary care: a cross-sectional study
Bramlage, Peter, Pittrow, David, Lehnert, Hendrik, Hoefler, Michael, Kirch, Wilhelm, Ritz, Eberhard and Wittchen, Hans-Ulrich. (2007) Frequency of albuminuria in primary care: a cross-sectional study. European Journal of Cardiovascular Prevention & Rehabilitation, Vol.14 (No.1). pp. 107-113. ISSN 1741-8267Full text not available from this repository.
Official URL: http://dx.doi.org/10.1097/01.hjr.0000224489.03221....
Background We aimed to assess the point prevalence of microalbuminuria (MAU) in a sample of unselected consecutive primary-care attendees, with particular focus on patients with diabetes mellitus (with and without additional concomitant diseases) and those with hypertension. Design Cross-sectional observational study in a nationwide representative sample of 1912 primary-care practices and a patient population consisting of 39 125 primary-care attendees. Diagnoses for diabetes, hypertension and co-morbidities were provided by the treating physician and complemented by blood pressure (BP) measurements and selected lab tests. Screening for microalbuminuria (>20 and <200 mu g/ml) was done with a spot urine dipstick test. Results The clinical diagnosis of nephropathy was assigned to 7.6% of patients. The point prevalence of MAU was 19.0% in the total sample; the proportion was 33.6% in diabetics whereas the diagnosis was assigned to only 71% in the total sample. Amongst diabetic patients with MAU, 92.6% had BP above the target value of <130/80 mmHg. Frequency rates rose with increasing BP (e.g. 20.6% in diabetic patients with BP<120/70 mmHg, and 36.3% in diabetic patients with BP>140/90 mmHg). Of note, patients with MAU had a higher burden of co-morbidity compared to those without MAU. Conclusions We found a high prevalence of MAU in primary care, particularly in diabetic patients. The frequency of MAU was closely related to the BP level and the degree of co-morbidity. The present study underlines the magnitude of the problem of MAU in primary care, and should serve as a starting point to initiate measures to address this important public health issue.
|Item Type:||Journal Article|
|Subjects:||Q Science > QM Human anatomy|
|Divisions:||Faculty of Medicine > Warwick Medical School|
|Journal or Publication Title:||European Journal of Cardiovascular Prevention & Rehabilitation|
|Publisher:||Lippincott Williams & Wilkins|
|Number of Pages:||7|
|Page Range:||pp. 107-113|
|Access rights to Published version:||Restricted or Subscription Access|
Actions (login required)